Quadrant Biosciences is an epigenetic diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary advancements in the early detection of autism spectrum disorder, Parkinson’s disease, and mTBI, through the application of the Clarifi® epigenetic diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions. In March 2020, we made the decision to pivot and allocate some of our resources to directly address the pandemic. By leveraging our expertise in RNA analysis, we have been able to be part of three exciting COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S. In September 2020, The Clarifi COVID-19 Test Kit obtained Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be used for the diagnosis fo SARS-CoV-2.
View Top Employees from Quadrant Biosciences IncWebsite | http://www.quadrantbiosciences.com |
Revenue | $12 million |
Employees | 94 (94 on RocketReach) |
Founded | 2015 |
Address | 505 Irving Ave Ste 3100AB, Syracuse, New York 13210, US |
Phone | (315) 614-2325 |
Technologies |
JavaScript,
HTML,
Twitter
+23 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Quadrant Biosciences Inc employee's phone or email?
The Quadrant Biosciences Inc annual revenue was $12 million in 2024.
Richard Bongo is the CFO of Quadrant Biosciences Inc.
94 people are employed at Quadrant Biosciences Inc.
Quadrant Biosciences Inc is based in Syracuse, New York.
The NAICS codes for Quadrant Biosciences Inc are [54171, 54, 541714, 541, 5417].
The SIC codes for Quadrant Biosciences Inc are [87, 873].